Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion

PLoS Neglected Tropical Diseases

Volumn 5, Issue 11, 2011, Pages

  Bale, Shridhar ^a   Liu, Tong ^b   Li, Sheng ^b   Wang, Yuhao ^b   Abelson, Dafna ^a   Fusco, Marnie ^a   Woods Jr , Virgil L ^b   Saphire, Erica ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; MUCIN; NEUTRALIZING ANTIBODY; POLYSACCHARIDE; THERMOLYSIN; VIRUS ENVELOPE PROTEIN;

ANTIGEN BINDING; ARTICLE; CELL PH; CONFORMATIONAL TRANSITION; CROSS PRESENTATION; DISSOCIATION; EBOLA VIRUS; ENDOSOME; ENZYME ACTIVITY; MEMBRANE FUSION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; CHEMICAL STRUCTURE; CHEMISTRY; DEUTERIUM HYDROGEN EXCHANGE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; MUTATION; PH; PHYSIOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN TERTIARY STRUCTURE;

ANTIBODIES, NEUTRALIZING; DEUTERIUM EXCHANGE MEASUREMENT; EBOLAVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYDROGEN-ION CONCENTRATION; MEMBRANE FUSION; MODELS, MOLECULAR; MUCINS; MUTATION; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY; THERMOLYSIN; VIRAL ENVELOPE PROTEINS;

EID: 82555169314     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001395     Document Type: Article

References (26)

1. Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, et al. (2008) Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 4: e1000212.
2. World Health Organization (2007) Ebola haemorrhagic fever in Uganda.
3. Feldmann H, Geisbert TW, (2011) Ebola haemorrhagic fever. Lancet 377: 849-862.
4. Falzarano D, Geisbert TW, Feldmann H, (2011) Progress in filovirus vaccine development: evaluating the potential for clinical use. Expert Rev Vaccines 10: 63-77.
5. Barrette RW, Metwally SA, Rowland JM, Xu L, Zaki SR, et al. (2009) Discovery of swine as a host for the Reston ebolavirus. Science 325: 204-206.
6. Sanchez A, Geisbert TW, Feldmann H, (2007) Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, editors. Fields Virology Philadelphia Lippincott Williams and Wilkins pp. 1409-1448.
7. White JM, Delos SE, Brecher M, Schornberg K, (2008) Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 43: 189-219.
8. Cosset FL, Lavillette D, (2011) Cell entry of enveloped viruses. Adv Genet 73: 121-183.
9. Sanchez A, Yang ZY, Xu L, Nabel GJ, Crews T, et al. (1998) Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol 72: 6442-6447.
10. Lee JE, Saphire EO, (2009) Neutralizing Ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it. Current Opinion in Structural Biology 19.
11. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM, (2005) Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308: 1643-1645.
12. Kaletsky RL, Simmons G, Bates P, (2007) Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 81: 13378-13384.
13. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, et al. (2006) Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 80: 4174-4178.
14. Sanchez A, (2007) Analysis of filovirus entry into Vero E6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis 196 (Suppl 2): S251-258.
15. Dube D, Brecher MB, Delos SE, Rose SC, Park EW, et al. (2009) The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. J Virol 83: 2883-2891.
16. Hood CL, Abraham J, Boyington JC, Leung K, Kwong PD, et al. (2010) Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. J Virol 84: 2972-2982.
17. Lee JE, Fusco MH, Hessell AJ, Oswald WB, Burton DR, et al. (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454: 177-183.
18. Lee JE, Fusco MH, Saphire EO, (2009) An efficient platform for screening expression and crystallization of glycoproteins produced in human cells. Nature Protocols 4: 592-604.
19. Hamuro Y, Anand GS, Kim JS, Juliano C, Stranz DD, et al. (2004) Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS). J Mol Biol 340: 1185-1196.
20. Zhang Z, Smith DL, (1993) Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci 2: 522-531.
21. Dias JM, Kuehne AI, Abelson DM, Bale S, Wong AC, et al. A Shared Structural Solution for Neutralizing Ebolaviruses. Nat Struct Mol Biolin press.
22. Weissenhorn W, Carfi A, Lee KH, Skehel JJ, Wiley DC, (1998) Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell 2: 605-616.
23. Malashkevich VN, Schneider BJ, McNally ML, Milhollen MA, Pang JX, et al. (1999) Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution. Proc Natl Acad Sci U S A 96: 2662-2667.
24. Woods VL Jr, Hamuro Y, (2001) High resolution, high-throughput amide deuterium exchange-mass spectrometry (DXMS) determination of protein binding site structure and dynamics: utility in pharmaceutical design. J Cell Biochem Suppl (Suppl 37): 89-98.
25. Wang J, Manicassamy B, Caffrey M, Rong L, (2011) Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry. Virol Sin 26: 156-170.
26. Shedlock DJ, Bailey MA, Popernack PM, Cunningham JM, Burton DR, et al. (2010) Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms. Virology 401: 228-235.